Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Syndax Pharmaceuticals, Inc. (SNDX) had Debt to Capital Ratio of 0.89 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$64.86M |
|
$-42.67M |
|
$2.63M |
|
$62.23M |
|
$99.07M |
|
$-34.20M |
|
$-8.47M |
|
$-42.67M |
|
$-42.67M |
|
$-42.67M |
|
$-42.67M |
|
$-42.67M |
|
$-42.67M |
|
$-34.20M |
|
$-34.87M |
|
88.26M |
|
88.26M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$471.18M |
|
$0.18M |
|
$1.49M |
|
$472.67M |
|
$86.17M |
|
$343.96M |
|
$344.87M |
|
$431.05M |
|
$41.62M |
|
$41.62M |
|
$41.62M |
|
88.54M |
|
| Cash Flow Statement Financials | |
$-50.34M |
|
$38.39M |
|
$7.92M |
|
$135.03M |
|
$131.00M |
|
$-4.04M |
|
$12.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.47 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.89 |
8.26 |
|
95.94% |
|
-52.73% |
|
-52.73% |
|
-- |
|
-65.79% |
|
-65.79% |
|
$-50.34M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.08 |
|
1.10 |
|
81.71 |
|
-102.53% |
|
-102.53% |
|
-9.03% |
|
-11.07% |
|
$0.47 |
|
$-0.57 |
|
$-0.57 |
|